1
|
Shimizu T, Lila ASA, Kitayama Y, Abe R, Takata H, Ando H, Ishima Y, Ishida T. Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes. Biol Pharm Bull 2024; 47:469-477. [PMID: 38383000 DOI: 10.1248/bpb.b23-00733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2024]
Abstract
Polyethylene glycol (PEG)-modified (PEGylated) cationic liposomes are frequently used as delivery vehicles for small interfering RNA (siRNA)-based drugs because of their ability to encapsulate/complex with siRNA and prolong the circulation half-life in vivo. Nevertheless, we have reported that subsequent intravenous (IV) injections of siRNA complexed with PEGylated cationic liposomes (PLpx) induces the production of anti-PEG immunoglobulin M (IgM), which accelerates the blood clearance of subsequent doses of PLpx and other PEGylated products. In this study, it is interesting that splenectomy (removal of spleen) did not prevent anti-PEG IgM induction by IV injection of PLpx. This indicates that B cells other than the splenic version are involved in anti-PEG IgM production under these conditions. In vitro and in vivo studies have shown that peritoneal cells also secrete anti-PEG IgM in response to the administration of PLpx. Interleukin-6 (IL-6) is a glycoprotein that is secreted by peritoneal immune cells and has been detected in response to the in vivo administration of PLpx. These observations indicate that IV injection of PLpx stimulates the proliferation/differentiation of peritoneal PEG-specific B cells into plasma cells via IL-6 induction, which results in the production of anti-PEG IgM from the peritoneal cavity of mice. Our results suggest the mutual contribution of peritoneal B cells as a potent anti-PEG immune response against PLpx.
Collapse
Affiliation(s)
- Taro Shimizu
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University
| | - Amr S Abu Lila
- Department of Pharmaceutics, College of Pharmacy, Hail University
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University
| | - Yuka Kitayama
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University
| | - Ryo Abe
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University
| | - Haruka Takata
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University
| | - Hidenori Ando
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University
| | - Yu Ishima
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University
| | - Tatsuhiro Ishida
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University
| |
Collapse
|
2
|
Takata H, Shimizu T, Yamade R, Elsadek NE, Emam SE, Ando H, Ishima Y, Ishida T. Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route. J Control Release 2023; 360:285-292. [PMID: 37355210 DOI: 10.1016/j.jconrel.2023.06.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Revised: 06/04/2023] [Accepted: 06/18/2023] [Indexed: 06/26/2023]
Abstract
Modifying the surface of nanoparticles with polyethylene glycol (PEG) is a commonly used approach for improving the in vitro stability of nanoparticles such as liposomes and increasing their circulation half-lives. We have demonstrated that, in certain conditions, an intravenous (i.v.) injection of PEGylated liposomes (PEG-Lip) induced anti-PEG IgM antibodies, which led to rapid clearance of second doses in mice. SARS-CoV-2 vaccines, composed of mRNA-containing PEGylated lipid nanoparticles, have been widely administered as intramuscular (i.m.) injections, so it is important to determine if PEGylated formulations can induce anti-PEG antibodies. If the favorable properties that PEGylation imparts to therapeutic nanoparticles are to be widely applicable this should apply to various routes of administration. However, there are few reports on the effect of different administration routes on the in vivo production of anti-PEG IgM. In this study, we investigated anti-PEG IgM production in mice following i.m., intraperitoneal (i.p.) and subcutaneous (s.c.) administration of PEG-Lip. PEG-Lip appeared to induce anti-PEG IgM by all the tested routes of administration, although the lipid dose causing maximum responses varied. Splenectomy attenuated the anti-PEG IgM production for all routes of administration, suggesting that splenic immune cells may have contributed to anti-PEG IgM production. Interestingly, in vitro experiments indicated that not only splenic cells but also cells in the peritoneal cavity induced anti-PEG IgM following incubation with PEG-Lip. These observations confirm previous experiments that have shown that measurable amounts of PEG-Lip administered i.p., i.m. or s.c. are absorbed to some extent into the blood circulation, where they can be distributed to the spleen and/or peritoneal cavity, and are recognized by B cells, triggering anti-PEG IgM production. The results obtained in this study have important implications for developing efficient PEGylated nanoparticular delivery system.
Collapse
Affiliation(s)
- Haruka Takata
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan
| | - Taro Shimizu
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan
| | - Rina Yamade
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan
| | - Nehal E Elsadek
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
| | - Sherif E Emam
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
| | - Hidenori Ando
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan
| | - Yu Ishima
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan
| | - Tatsuhiro Ishida
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan.
| |
Collapse
|
3
|
A Novel 89Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): "Lactosome" Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy. Life (Basel) 2021; 11:life11020158. [PMID: 33670777 PMCID: PMC7923095 DOI: 10.3390/life11020158] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2021] [Revised: 02/13/2021] [Accepted: 02/15/2021] [Indexed: 12/22/2022] Open
Abstract
“Theranostics,” a new concept of medical advances featuring a fusion of therapeutic and diagnostic systems, provides promising prospects in personalized medicine, especially cancer. The theranostics system comprises a novel 89Zr-labeled drug delivery system (DDS), derived from the novel biodegradable polymeric micelle, “Lactosome” nanoparticles conjugated with specific shortened IgG variant, and aims to successfully deliver therapeutically effective molecules, such as the apoptosis-inducing small interfering RNA (siRNA) intracellularly while offering simultaneous tumor visualization via PET imaging. A 27 kDa-human single chain variable fragment (scFv) of IgG to establish clinically applicable PET imaging and theranostics in cancer medicine was fabricated to target mesothelin (MSLN), a 40 kDa-differentiation-related cell surface glycoprotein antigen, which is frequently and highly expressed by malignant tumors. This system coupled with the cell penetrating peptide (CPP)-modified and photosensitizer (e.g., 5, 10, 15, 20-tetrakis (4-aminophenyl) porphyrin (TPP))-loaded Lactosome particles for photochemical internalized (PCI) driven intracellular siRNA delivery and the combination of 5-aminolevulinic acid (ALA) photodynamic therapy (PDT) offers a promising nano-theranostic-based cancer therapy via its targeted apoptosis-inducing feature. This review focuses on the combined advances in nanotechnology and material sciences utilizing the “89Zr-labeled CPP and TPP-loaded Lactosome particles” and future directions based on important milestones and recent developments in this platform.
Collapse
|
4
|
Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon. Drug Deliv Transl Res 2018; 9:66-75. [DOI: 10.1007/s13346-018-0588-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
5
|
Yamazaki Y, Nambu Y, Ohmae M, Sugai M, Kimura S. Immune responses against Lewis Y tumor-associated carbohydrate antigen displayed densely on self-assembling nanocarriers. Org Biomol Chem 2018; 16:8095-8105. [DOI: 10.1039/c8ob01955j] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Immune responses against Lewis Y (LY) displayed at varying densities on the nanocarriers were studied.
Collapse
Affiliation(s)
- Yuji Yamazaki
- Department of Material Chemistry
- Graduate School of Engineering
- Kyoto University
- Kyoto 615-8510
- Japan
| | - Yukiko Nambu
- Division of Molecular Genetics
- Department of Biochemistry and Bioinformative Sciences
- School of Medicine
- University of Fukui
- Fukui 910-1193
| | - Masashi Ohmae
- Department of Material Chemistry
- Graduate School of Engineering
- Kyoto University
- Kyoto 615-8510
- Japan
| | - Manabu Sugai
- Division of Molecular Genetics
- Department of Biochemistry and Bioinformative Sciences
- School of Medicine
- University of Fukui
- Fukui 910-1193
| | - Shunsaku Kimura
- Department of Material Chemistry
- Graduate School of Engineering
- Kyoto University
- Kyoto 615-8510
- Japan
| |
Collapse
|
6
|
Kim CJ, Hara E, Watabe N, Hara I, Kimura S. Modulation of immunogenicity of poly(sarcosine) displayed on various nanoparticle surfaces due to different physical properties. J Pept Sci 2017; 23:889-898. [DOI: 10.1002/psc.3053] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2017] [Revised: 09/21/2017] [Accepted: 10/05/2017] [Indexed: 12/16/2022]
Affiliation(s)
- Cheol Joo Kim
- Department of Material Chemistry, Graduate School of Engineering Kyoto University Kyoto Daigaku‐Katsura, Nishikyo‐ku Kyoto 615‐8510 Japan
| | - Eri Hara
- Department of Experimental Therapeutics Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital 53 Shogoin kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 Japan
| | - Naoki Watabe
- Department of Material Chemistry, Graduate School of Engineering Kyoto University Kyoto Daigaku‐Katsura, Nishikyo‐ku Kyoto 615‐8510 Japan
| | - Isao Hara
- Technology Research Laboratory Shimadzu Corporation 3‐9‐4 Hikaridai, Seika‐cho, Soraku‐gun 619‐0237 Kyoto Japan
| | - Shunsaku Kimura
- Department of Material Chemistry, Graduate School of Engineering Kyoto University Kyoto Daigaku‐Katsura, Nishikyo‐ku Kyoto 615‐8510 Japan
| |
Collapse
|
7
|
Chan BA, Xuan S, Li A, Simpson JM, Sternhagen GL, Yu T, Darvish OA, Jiang N, Zhang D. Polypeptoid polymers: Synthesis, characterization, and properties. Biopolymers 2017; 109. [DOI: 10.1002/bip.23070] [Citation(s) in RCA: 54] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2017] [Revised: 09/13/2017] [Accepted: 09/20/2017] [Indexed: 12/20/2022]
Affiliation(s)
- Brandon A. Chan
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Sunting Xuan
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Ang Li
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Jessica M. Simpson
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Garrett L. Sternhagen
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Tianyi Yu
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Omead A. Darvish
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Naisheng Jiang
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| | - Donghui Zhang
- Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge70803Los Angeles
| |
Collapse
|
8
|
Lenartić M, Jelenčić V, Zafirova B, Ožanič M, Marečić V, Jurković S, Sexl V, Šantić M, Wensveen FM, Polić B. NKG2D Promotes B1a Cell Development and Protection against Bacterial Infection. THE JOURNAL OF IMMUNOLOGY 2017; 198:1531-1542. [PMID: 28087665 DOI: 10.4049/jimmunol.1600461] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/17/2016] [Accepted: 12/12/2016] [Indexed: 02/06/2023]
Abstract
NKG2D is a potent activating receptor that is expressed on cytotoxic immune cells such as CD8 T and NK cells, where it promotes cytotoxicity after binding stress ligands on infected or transformed cells. On NK cell precursors NKG2D modulates proliferation and maturation. Previously, we observed that NKG2D deficiency affects peripheral B cell numbers. In this study, we show that NKG2D regulates B1a cell development and function. We find that mice deficient for NKG2D have a strong reduction of B1a cell numbers. As a result, NKG2D-deficient mice produce significantly less Ag-specific IgM Abs upon immunization with T cell-independent Ags, and they are more susceptible to Gram-negative sepsis. Klrk1-/- B1a cells are also functionally impaired and they fail to provide protection against Francisella novicida upon adoptive transfer. Using mixed bone marrow chimeric mice, we show that the impact of NKG2D deficiency on B1a cell development is cell intrinsic. No changes in homeostatic turnover and homing of B cells were detectable, limiting the effects of NKG2D to modulation of the hematopoietic development of B1a cells. Using conditional ablation, we demonstrate that the effect of NKG2D on B1a cell development occurs at a developmental stage that precedes the common lymphoid progenitor. Our findings reveal an unexpected new role for NKG2D in the regulation of B1a cell development. The protective effects of this activating receptor therefore reach beyond that of cytotoxic cells, stimulating the immune system to fight bacterial infections by promoting development of innate-like B cells.
Collapse
Affiliation(s)
- Maja Lenartić
- Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
| | - Vedrana Jelenčić
- Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
| | - Biljana Zafirova
- Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.,Laboratory of Dendritic Cell Immunobiology, Immunology Department, Institute Pasteur, 75015 Paris, France
| | - Mateja Ožanič
- Department of Microbiology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
| | - Valentina Marečić
- Department of Microbiology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
| | - Slaven Jurković
- Department of Medical Physics, University Hospital Rijeka, 51000 Rijeka, Croatia
| | - Veronika Sexl
- Department of Biomedical Sciences, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, 1210 Vienna, Austria; and
| | - Marina Šantić
- Department of Microbiology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
| | - Felix M Wensveen
- Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.,Department of Experimental Immunology, Academic Medical Center, 1105 Amsterdam, the Netherlands
| | - Bojan Polić
- Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia;
| |
Collapse
|
9
|
Yamazaki Y, Watabe N, Obata H, Hara E, Ohmae M, Kimura S. Immune activation with peptide assemblies carrying Lewis y tumor-associated carbohydrate antigen. J Pept Sci 2016; 23:189-197. [DOI: 10.1002/psc.2926] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2016] [Revised: 08/19/2016] [Accepted: 08/30/2016] [Indexed: 11/11/2022]
Affiliation(s)
- Yuji Yamazaki
- Department of Material Chemistry, Graduate School of Engineering; Kyoto University; Kyoto Daigaku-Katsura, Nishikyo-ku Kyoto 615-8510 Japan
| | - Naoki Watabe
- Department of Material Chemistry, Graduate School of Engineering; Kyoto University; Kyoto Daigaku-Katsura, Nishikyo-ku Kyoto 615-8510 Japan
| | - Hiroaki Obata
- Department of Material Chemistry, Graduate School of Engineering; Kyoto University; Kyoto Daigaku-Katsura, Nishikyo-ku Kyoto 615-8510 Japan
| | - Eri Hara
- Department of Experimental Therapeutics, Institute for Advancement of Clinical and Translational Science; Kyoto University Hospital; 53 Shogoin kawahara-cho, Sakyo-ku Kyoto 606-8507 Japan
| | - Masashi Ohmae
- Department of Material Chemistry, Graduate School of Engineering; Kyoto University; Kyoto Daigaku-Katsura, Nishikyo-ku Kyoto 615-8510 Japan
| | - Shunsaku Kimura
- Department of Material Chemistry, Graduate School of Engineering; Kyoto University; Kyoto Daigaku-Katsura, Nishikyo-ku Kyoto 615-8510 Japan
| |
Collapse
|
10
|
Ohmae M, Kojima M, Mihara K, Yamazaki Y, Hara I, Hara E, Kimura S. Reduced immune response to polymeric micelles coating sialic acids. Bioorg Med Chem Lett 2016; 26:4976-4982. [DOI: 10.1016/j.bmcl.2016.09.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2016] [Revised: 08/26/2016] [Accepted: 09/02/2016] [Indexed: 12/12/2022]
|
11
|
Gangloff N, Ulbricht J, Lorson T, Schlaad H, Luxenhofer R. Peptoids and Polypeptoids at the Frontier of Supra- and Macromolecular Engineering. Chem Rev 2015; 116:1753-802. [DOI: 10.1021/acs.chemrev.5b00201] [Citation(s) in RCA: 190] [Impact Index Per Article: 21.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Niklas Gangloff
- Functional Polymer
Materials, Chair for Chemical Technology of Materials Synthesis, University of Würzburg, Röntgenring 11, 97070 Würzburg, Germany
| | - Juliane Ulbricht
- Functional Polymer
Materials, Chair for Chemical Technology of Materials Synthesis, University of Würzburg, Röntgenring 11, 97070 Würzburg, Germany
| | - Thomas Lorson
- Functional Polymer
Materials, Chair for Chemical Technology of Materials Synthesis, University of Würzburg, Röntgenring 11, 97070 Würzburg, Germany
| | - Helmut Schlaad
- Institute of Chemistry, University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam, Germany
| | - Robert Luxenhofer
- Functional Polymer
Materials, Chair for Chemical Technology of Materials Synthesis, University of Würzburg, Röntgenring 11, 97070 Würzburg, Germany
| |
Collapse
|
12
|
Micelle-Based Adjuvants for Subunit Vaccine Delivery. Vaccines (Basel) 2015; 3:803-13. [PMID: 26426060 PMCID: PMC4693219 DOI: 10.3390/vaccines3040803] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2015] [Revised: 09/08/2015] [Accepted: 09/22/2015] [Indexed: 11/20/2022] Open
Abstract
In the development of subunit vaccines with purified or recombinant antigens for cancer and infectious diseases, the design of improved and safe adjuvants able to efficiently target the antigen presenting cells, such as dendritic cells, represents a crucial challenge. Nanoparticle-based antigen delivery systems have been identified as an innovative strategy to improve the efficacy of subunit vaccines. Among them, self-assembled micellar nanoparticles from amphiphilic (macro)molecules have recently emerged as promising candidates. In this short review, we report on the recent research findings highlighting the versatility and potential of such systems in vaccine delivery.
Collapse
|